MPP Annual Report 2012

During 2012, the MPP built on good work from the year before by out-licensing medicines to five generic manufacturers and continued research work leading to the ongoing development of useful information resources such as the Patent Status Database and the ARV priority list. An overview of the achievements for the year have been summarised in the annual report.

The annual report (1.7mb, PDF) is now available online.

This page is also available in: French, Spanish

Comments are closed.